Major Depressive Disorder
📧 Sign up to get email alerts when something new happens for Major Depressive Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2010-09-17Clinical Trial Update: Pharmacogenomics Studies of Antidepressants [Phase 4]
A Phase 4 pharmacogenomics study update in Major Depressive Disorder. It focuses on how genetic factors influence response to Venlafaxine an…
-
CLINICAL_TRIALS research · 2010-09-13Clinical Trial Update: The Nocebo Effect: a Prospective Study of Informed Consent as a Factor in the Prevalence of SSRI's Side Effects [NA]
A prospective study examining whether informed consent and patient expectations influence the reporting of side effects from selective serot…
-
CLINICAL_TRIALS trial_result · 2010-09-10Clinical Trial Update: Transcranial Direct Current Stimulation (tDCS) Augmentation by D-Cycloserine as a Treatment for Depression [Phase 2]
A Phase 2 clinical trial evaluated adding D-cycloserine to transcranial direct current stimulation (tDCS) for depression. The study, includi…
-
CLINICAL_TRIALS trial_result · 2010-09-10Clinical Trial Update: Improving Psychological Wellness After Acquired Brain Injury [NA]
This clinical trial update reports on a Toronto Rehabilitation Institute-sponsored study aimed at improving psychological wellness after acq…
-
FDA approval · 2010-09-08FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
The FDA approved a supplemental application for PRISTIQ Extended-Release (desvenlafaxine succinate) from Wyeth Pharmaceuticals, a subsidiary…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2010-08-31Clinical Trial Update: Functional Neuroimaging in Depression [Phase 2]
This document reports an update on a Phase 2 clinical trial exploring functional neuroimaging in individuals with major depressive disorder.…
-
FDA approval · 2010-08-30FDA Approved: BUPROPION HYDROCHLORIDE XL — Supplemental Application (Actavis Pharma, Inc.)
FDA approved a supplemental application for Bupropion Hydrochloride XL (Actavis), a generic extended-release formulation of bupropion hydroc…
-
CLINICAL_TRIALS trial_result · 2010-08-27Clinical Trial Update: A Study With Arctic Root Compared With the Extract When Combined With Schizandra and Russian Root (Adapt 232), Standardized Ginseng Extract and Placebo Regarding Impact on the Level of Energy, Ability to Work Under Stress, Quality of Life and Wellbeing, in Middleaged Women Who Are Still Employed [NA]
A completed trial assessing the impact of Arctic Root versus an extract, both combined with Schizandra and Russian Root, on energy, ability …
-
CLINICAL_TRIALS trial_result · 2010-08-20Clinical Trial Update: Brain Mechanisms and Targeting Insomnia in Major Depression [Phase 4]
A Phase 4 clinical trial conducted by UCLA investigates brain mechanisms and approaches to treating insomnia in patients with Major Depressi…
-
FDA approval · 2010-08-18FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Sun Pharmaceutical Industries, Inc.)
FDA approved Sun Pharmaceutical Industries' generic venlafaxine hydrochloride under an Original Application. It is indicated for major depre…
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: The Efficacy of the Caregiver Psychoeducational Consultation Program [Phase 2, Phase 3]
A clinical trial update on the efficacy of a caregiver psychoeducational consultation program in Phase 2 and Phase 3.
-
CLINICAL_TRIALS trial_result · 2010-08-16Clinical Trial Update: Study on the Tolerability of Duloxetine in Depressed Patients With Parkinson's Disease [Phase 4]
A Phase 4 study evaluated the tolerability of duloxetine in patients with major depressive disorder and Parkinson's disease; results were po…
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Switching to Duloxetine in Patients With Depression [Phase 4]
Phase 4 clinical trial update examining switching to duloxetine in adults with major depressive disorder; results have been posted following…
-
CLINICAL_TRIALS research · 2010-08-06Clinical Trial Update: Cognitive-Behavioral Therapy for Sleep Disturbance in Patients Undergoing Hemodialysis [NA]
A clinical trial update examines cognitive-behavioral therapy to address sleep disturbance in patients undergoing hemodialysis, focusing on …
-
FDA approval · 2010-08-04FDA Approved: VENLAFAXINE HYDROCHLORIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for Venlafaxine hydrochloride by Teva Pharmaceuticals USA, Inc.
-
CLINICAL_TRIALS research · 2010-07-21Clinical Trial Update: Online Support Groups for Depression and Anxiety [Phase 1, Phase 2]
A clinical trial from University College London is studying online support groups for depression and anxiety across Phase 1 and Phase 2, wit…
-
FDA approval · 2010-07-09FDA Approved: PRISTIQ EXTENDED-RELEASE — Supplemental Application (Wyeth Pharmaceuticals LLC, a subsidiary of Pfizer Inc.)
FDA approved a supplemental application for Pristiq Extended-Release (desvenlafaxine succinate) submitted by Wyeth/Pfizer.
-
FDA approval · 2010-07-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (Apnar Pharma LP)
FDA approved a supplemental application for bupropion hydrochloride from Apnar Pharma LP, approving changes associated with this generic pro…
-
FDA approval · 2010-07-08FDA Approved: BUPROPION HYDROCHLORIDE — Supplemental Application (BluePoint Laboratories)
FDA approves BluePoint Laboratories' supplemental application for Bupropion Hydrochloride under ANDA 076143, approving changes to the approv…
-
CLINICAL_TRIALS trial_result · 2010-07-01Clinical Trial Update: Trauma and Truth Interventions (NET) Versus Conflict Resolution and Social Skills Trainings for Vulnerable Youths in Northern Uganda [NA]
A completed clinical trial comparing Trauma and Truth Interventions (NET) to Conflict Resolution and Social Skills Trainings for vulnerable …
-
CLINICAL_TRIALS trial_result · 2010-06-30Clinical Trial Update: Cognitive Behavioural Analysis System of Psychotherapy (CBASp) Versus Escitalopram in Chronic Depression [Phase 3]
Phase 3 trial comparing Cognitive Behavioural Analysis System of Psychotherapy (CBASP) with escitalopram for chronic depression. Trial statu…
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Study Evaluating Desvenlafaxine Succinate Sustained Release (DVS SR) vs. Escitalopram in Postmenopausal Women [Phase 3]
Phase 3 trial comparing desvenlafaxine succinate sustained release to escitalopram in postmenopausal women with depression has completed wit…
-
CLINICAL_TRIALS trial_result · 2010-06-29Clinical Trial Update: Open-Label, Randomized Study Evaluating Treatment With Venlafaxine Extended-Release Plus Dialogues Time to Talk Program [Phase 4]
Open-label, randomized Phase 4 trial evaluating venlafaxine extended-release combined with the Dialogues Time to Talk program for major depr…
-
FDA approval · 2010-06-28FDA Approved: VENLAFAXINE HYDROCHLORIDE — Original Application (Teva Pharmaceuticals USA, Inc.)
FDA approved Teva's venlafaxine hydrochloride as an Original Application generic (ANDA). The approval enables a generic version of venlafaxi…
-
FDA approval · 2010-06-25FDA Approved: FLUOXETINE — Supplemental Application (QUALLENT PHARMACEUTICALS HEALTH LLC)
FDA approved a supplemental application for fluoxetine hydrochloride (fluoxetine) from QUALLENT PHARMACEUTICALS HEALTH LLC, updating the app…